Shares of Catabasis Pharmaceuticals (NASDAQ: CATB) are surging on Friday premarket after the company announced it has acquired Quellis Biosciences Inc, in a stock for stock transaction.
The company revealed it has also entered into an agreement to sell Series X convertible preferred stock in a private placement to a group of institutional accredited investors led by Perceptive Advisors with participation from new and existing investors.
Catabasis expect to raise approximately $110 million and will look to use the proceeds to enable the completion of IND-enabling studies, Phase 1a, and Phase 1b/ 2 clinical trials for the lead program QLS-215 hereditary angioedema, a potentially life-threatening disease.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
“Catabasis has worked diligently with external advisors to explore and evaluate a range of strategic options, and the Board and management team believe that this transaction represents an opportunity to create substantial value for Catabasis’ stockholders,” said Kenneth Bate, Chair of the Catabasis Board of Directors.
Once the acquisition is completed, Catabasis expects to have cash, cash equivalents, and short-term investments of approximately $150 million and a cash runway through 2023.
Its share price has climbed over 53.91% premarket currently trading at $3.76 following Thursday’s close at $2.42.
